Imperial Brands CEO: U.S. menthol cigarette ban likely years away
LONDON (Reuters) - The outcome of moves to ban menthol cigarettes in the United States remains uncertain but implementation w...
May 15, 2024
Getinge limits sale of heart devices in the US after FDA warning
(Reuters) - Sweden's Getinge will limit sales of some of its heart products in the U.S., the medical equipment maker said lat...
May 15, 2024
Roche says FDA approves HPV self-test in US
BERLIN (Reuters) - Swiss drugmaker Roche on Wednesday said the US Food and Drug Administration (FDA) has approved its human p...
May 15, 2024
Taiwan says WHO should let it attend all its meetings
TAIPEI (Reuters) - Taiwan Foreign Minister Joseph Wu called on the World Health Organization on Wednesday to allow the island...
May 15, 2024
Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA
(Reuters) - Eisai and partner Biogen said on Tuesday that the Japanese drugmaker has begun submitting data on a rolling basis...
May 14, 2024
Eli Lilly reaches settlement with spa selling Mounjaro, Zepbound knockoffs
(Reuters) - Eli Lilly has entered into a settlement deal with a medi spa that had sold counterfeit versions of its popular di...
May 14, 2024
Activist Jana Partners built position in QuidelOrtho in first quarter, sources say
By Svea Herbst-Bayliss (Reuters) - Activist investor Jana Partners built a new stake in U.S. diagnostics company QuidelOrtho ...
May 14, 2024
Grifols swings to profit, says debt reduction on track
By Joan Faus BARCELONA (Reuters) - Spanish drugmaker Grifols swung to a first-quarter net profit of 21 million euros ($23 mil...
May 14, 2024
CDC makes public influenza A wastewater data to assist bird flu probe
(Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday released data on influenza A found in wastew...
May 14, 2024
US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine
(Reuters) - The U.S. Food and Drug Administration has declined to approve the expanded use of Dynavax Technologies' hepatitis...
May 14, 2024